Literature DB >> 8889213

Fractions from commercial collagenase preparations: use in enzymic isolation of the islets of Langerhans from porcine pancreas.

G Klöck1, M B Kowalski, B J Hering, M E Eiden, A Weidemann, S Langer, U Zimmermann, K Federlin, R G Bretzel.   

Abstract

Transplantation of isolated islets of Langerhans is an intriguing possibility for the treatment of diabetes mellitus. The isolation of islets from pancreata requires the specific dissociation of the tissue. Commercial collagenases from Clostridium histolyticum are widely used for this purpose. Unfortunately, the effectiveness of these commercial enzymes is not predictable and differs considerably between suppliers and even from lot to lot. This is due mainly to differences in their specific collagenase activity and to the presence of other lytic enzymes, as well as to other contaminants. Free flow zone electrophoresis (FFZE) was used to separate the effective protein components from undesired compounds and to prepare a digestive enzyme mixture with controlled composition of lytic activities. Fractionation of crude collagenases by FFZE resulted in partially purified protein fractions that were enriched for collagenase and tryptic activities, and contained only trace amounts of neutral protease. These preparations proved to be highly effective in an in vitro assay for the libration of viable islets from porcine pancreas. To scale up the production of these collagenases with defined enzyme composition, we fractionated two different lots of a commercial collagenase from C. histolyticum (one lot effective in islet isolation, the other not) by using fast protein liquid chromatography (FPLC) on hydroxyapatite. Again, high efficacy of islet release from pancreatic tissue was correlated to high specific tryptic and collagenase activities and low levels of neutral protease. The chromatographic protocol developed in this study converted a non-effective collagenase lot into a preparation that allowed successful islet isolation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889213     DOI: 10.1177/096368979600500504

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.139


  3 in total

Review 1.  Enzyme Development for Human Islet Isolation: Five Decades of Progress or Stagnation?

Authors:  Daniel Brandhorst; Heide Brandhorst; Paul R V Johnson
Journal:  Rev Diabet Stud       Date:  2017-06-12

2.  Improved enzymatic isolation of fibroblasts for the creation of autologous skin substitutes.

Authors:  Hongjun Wang; Clemens A Van Blitterswijk; Marion Bertrand-De Haas; Arnold H Schuurman; Evert N Lamme
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Sep-Oct       Impact factor: 2.416

3.  Quantifying the Effects of Different Neutral Proteases on Human Islet Integrity.

Authors:  Heide Brandhorst; Paul R V Johnson; Olle Korsgren; Daniel Brandhorst
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.